Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Mar. 31, 2018
CURRENT ASSETS
Cash	$ 63,647	$ 843,643
Accounts receivable, net	208,099
Inventory - in transit	24,604
Harmonized sales tax recoverable	59,925	35,737
Deposits and other receivables	101,385	17,046
Total current assets	457,660	896,426
NON-CURRENT ASSETS
Deposits and other receivables	33,000	33,000
TOTAL ASSETS	490,660	929,426
CURRENT LIABILITIES
Accounts payable and accrued liabilities [Note 4]	1,400,642	756,179
Convertible promissory notes [Note 5]	867,699
TOTAL LIABILITIES	2,268,341	756,179
STOCKHOLDERS' DEFICIENCY (EQUITY)
Preferred stock, $0.001 par value, 10,000,000 authorized as at March 31, 2019 and March 31, 2018, respectively, 1 share issued and outstanding as at March 31, 2019 and March 31, 2018, respectively [Note 7]	1	1
Common stock, $0.001 par value, 125,000,000 authorized as at March 31, 2019 and March 31, 2018, respectively. Issued and outstanding common shares: 31,048,571 and 23,713,602 as at March 31, 2019 and 2018, respectively, and exchangeable shares of 4,313,085 and 8,143,944 outstanding as at March 31, 2019 and 2018, respectively [Note 7]	35,362	31,858
Shares to be issued (62,085 and 20,250 shares of common stock as at March 31, 2019 and 2018, respectively) [Note 7]	91,498	69,963
Additional paid-in-capital	33,889,916	27,161,984
Accumulated other comprehensive loss	(754,963)	(643,129)
Accumulated deficit	(35,039,495)	(26,447,430)
TOTAL STOCKHOLDERS' DEFICIENCY (EQUITY)	(1,777,681)	173,247
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY (EQUITY)	$ 490,660	$ 929,426